247 related articles for article (PubMed ID: 28624185)
1. The Formation of Nanoparticles between Small Interfering RNA and Amphipathic Cell-Penetrating Peptides.
Pärnaste L; Arukuusk P; Langel K; Tenson T; Langel Ü
Mol Ther Nucleic Acids; 2017 Jun; 7():1-10. PubMed ID: 28624185
[TBL] [Abstract][Full Text] [Related]
2. Comparison of cationic and amphipathic cell penetrating peptides for siRNA delivery and efficacy.
Mo RH; Zaro JL; Shen WC
Mol Pharm; 2012 Feb; 9(2):299-309. PubMed ID: 22171592
[TBL] [Abstract][Full Text] [Related]
3. Cell penetration: scope and limitations by the application of cell-penetrating peptides.
Reissmann S
J Pept Sci; 2014 Oct; 20(10):760-84. PubMed ID: 25112216
[TBL] [Abstract][Full Text] [Related]
4. An Amphipathic Structure of a Dipropylglycine-Containing Helical Peptide with Sufficient Length Enables Safe and Effective Intracellular siRNA Delivery.
Oba M; Shibuya M; Yamaberi Y; Yokoo H; Uchida S; Ueda A; Tanaka M
Chem Pharm Bull (Tokyo); 2023; 71(3):250-256. PubMed ID: 36858531
[TBL] [Abstract][Full Text] [Related]
5. How Cargo Identity Alters the Uptake of Cell-Penetrating Peptide (CPP)/Cargo Complexes: A Study on the Effect of Net Cargo Charge and Length.
Hymel HC; Rahnama A; Sanchez OM; Liu D; Gauthier TJ; Melvin AT
Cells; 2022 Apr; 11(7):. PubMed ID: 35406759
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of siRNA transfection by the optimization of fatty acid length and histidine content in the CPP.
Porosk L; Arukuusk P; Põhako K; Kurrikoff K; Kiisholts K; Padari K; Pooga M; Langel Ü
Biomater Sci; 2019 Sep; 7(10):4363-4374. PubMed ID: 31411219
[TBL] [Abstract][Full Text] [Related]
7. Cell penetrating peptides: efficient vectors for delivery of nanoparticles, nanocarriers, therapeutic and diagnostic molecules.
Farkhani SM; Valizadeh A; Karami H; Mohammadi S; Sohrabi N; Badrzadeh F
Peptides; 2014 Jul; 57():78-94. PubMed ID: 24795041
[TBL] [Abstract][Full Text] [Related]
8. Molecular parameters of siRNA--cell penetrating peptide nanocomplexes for efficient cellular delivery.
van Asbeck AH; Beyerle A; McNeill H; Bovee-Geurts PH; Lindberg S; Verdurmen WP; Hällbrink M; Langel U; Heidenreich O; Brock R
ACS Nano; 2013 May; 7(5):3797-807. PubMed ID: 23600610
[TBL] [Abstract][Full Text] [Related]
9. Optimisation of vectorisation property: A comparative study for a secondary amphipathic peptide.
Konate K; Lindberg MF; Vaissiere A; Jourdan C; Aldrian G; Margeat E; Deshayes S; Boisguerin P
Int J Pharm; 2016 Jul; 509(1-2):71-84. PubMed ID: 27224007
[TBL] [Abstract][Full Text] [Related]
10. Cell-penetrating peptides with nanoparticles hybrid delivery vectors and their uptake pathways.
Dowaidar M
Mitochondrion; 2024 May; 78():101906. PubMed ID: 38797356
[TBL] [Abstract][Full Text] [Related]
11. Cell-penetrating peptide-conjugated lipid nanoparticles for siRNA delivery.
Asai T; Tsuzuku T; Takahashi S; Okamoto A; Dewa T; Nango M; Hyodo K; Ishihara H; Kikuchi H; Oku N
Biochem Biophys Res Commun; 2014 Feb; 444(4):599-604. PubMed ID: 24486551
[TBL] [Abstract][Full Text] [Related]
12. Intracellular Delivery of Molecular Cargo Using Cell-Penetrating Peptides and the Combination Strategies.
Li H; Tsui TY; Ma W
Int J Mol Sci; 2015 Aug; 16(8):19518-36. PubMed ID: 26295227
[TBL] [Abstract][Full Text] [Related]
13. Trends in the Binding of Cell Penetrating Peptides to siRNA: A Molecular Docking Study.
Rathnayake PV; Gunathunge BG; Wimalasiri PN; Karunaratne DN; Ranatunga RJ
J Biophys; 2017; 2017():1059216. PubMed ID: 28321253
[TBL] [Abstract][Full Text] [Related]
14. Peptide vectors for the nonviral delivery of nucleic acids.
Hoyer J; Neundorf I
Acc Chem Res; 2012 Jul; 45(7):1048-56. PubMed ID: 22455499
[TBL] [Abstract][Full Text] [Related]
15. Recent in vivo advances in cell-penetrating peptide-assisted drug delivery.
Kurrikoff K; Gestin M; Langel Ü
Expert Opin Drug Deliv; 2016; 13(3):373-87. PubMed ID: 26634750
[TBL] [Abstract][Full Text] [Related]
16. New generation of cell-penetrating peptides: Functionality and potential clinical application.
Reissmann S; Filatova MP
J Pept Sci; 2021 May; 27(5):e3300. PubMed ID: 33615648
[TBL] [Abstract][Full Text] [Related]
17. VEGF siRNA Delivery by a Cancer-Specific Cell-Penetrating Peptide.
Lee YW; Hwang YE; Lee JY; Sohn JH; Sung BH; Kim SC
J Microbiol Biotechnol; 2018 Mar; 28(3):367-374. PubMed ID: 29316746
[TBL] [Abstract][Full Text] [Related]
18. Modeling of non-covalent complexes of the cell-penetrating peptide CADY and its siRNA cargo.
Crowet JM; Lins L; Deshayes S; Divita G; Morris M; Brasseur R; Thomas A
Biochim Biophys Acta; 2013 Feb; 1828(2):499-509. PubMed ID: 23000699
[TBL] [Abstract][Full Text] [Related]
19. A retro-inverso cell-penetrating peptide for siRNA delivery.
Vaissière A; Aldrian G; Konate K; Lindberg MF; Jourdan C; Telmar A; Seisel Q; Fernandez F; Viguier V; Genevois C; Couillaud F; Boisguerin P; Deshayes S
J Nanobiotechnology; 2017 Apr; 15(1):34. PubMed ID: 28454579
[TBL] [Abstract][Full Text] [Related]
20. Tips and Tools to Understand Direct Membrane Translocation of siRNA-Loaded WRAP-Based Nanoparticles.
Deshayes S; Konate K; Vivès E; Boisguérin P
Methods Mol Biol; 2022; 2383():475-490. PubMed ID: 34766308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
